| 6. Human Diseases |
6.12 Drug resistance: Antineoplastic |
hsa01522 |
Endocrine resistance |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04010 |
MAPK signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04015 |
Rap1 signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04068 |
FoxO signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04071 |
Sphingolipid signaling pathway |
| 4. Cellular Processes |
4.2 Cell growth and death |
hsa04114 |
Oocyte meiosis |
| 4. Cellular Processes |
4.2 Cell growth and death |
hsa04218 |
Cellular senescence |
| 5. Organismal Systems |
5.3 Circulatory system |
hsa04261 |
Adrenergic signaling in cardiomyocytes |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04370 |
VEGF signaling pathway |
| 5. Organismal Systems |
5.8 Development |
hsa04380 |
Osteoclast differentiation |
| 4. Cellular Processes |
4.3 Cellular community - eukaryotes |
hsa04550 |
Signaling pathways regulating pluripotency of stem cells |
| 5. Organismal Systems |
5.1 Immune system |
hsa04611 |
Platelet activation |
| 5. Organismal Systems |
5.1 Immune system |
hsa04620 |
Toll-like receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04621 |
NOD-like receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04622 |
RIG-I-like receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04625 |
C-type lectin receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04657 |
IL-17 signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04658 |
Th1 and Th2 cell differentiation |
| 5. Organismal Systems |
5.1 Immune system |
hsa04659 |
Th17 cell differentiation |
| 5. Organismal Systems |
5.1 Immune system |
hsa04660 |
T cell receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04664 |
Fc epsilon RI signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04668 |
TNF signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04670 |
Leukocyte transendothelial migration |
| 5. Organismal Systems |
5.10 Environmental adaptation |
hsa04714 |
Thermogenesis |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04722 |
Neurotrophin signaling pathway |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04723 |
Retrograde endocannabinoid signaling |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04728 |
Dopaminergic synapse |
| 5. Organismal Systems |
5.7 Sensory system |
hsa04750 |
Inflammatory mediator regulation of TRP channels |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04912 |
GnRH signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04914 |
Progesterone-mediated oocyte maturation |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04917 |
Prolactin signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04926 |
Relaxin signaling pathway |
| 6. Human Diseases |
6.7 Endocrine and metabolic diseases |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
| 6. Human Diseases |
6.4 Neurodegenerative diseases |
hsa05014 |
Amyotrophic lateral sclerosis (ALS) |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05120 |
Epithelial cell signaling in Helicobacter pylori infection |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05131 |
Shigellosis |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05132 |
Salmonella infection |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05133 |
Pertussis |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05135 |
Yersinia infection |
| 6. Human Diseases |
6.10 Infectious diseases: Parasitic |
hsa05140 |
Leishmaniasis |
| 6. Human Diseases |
6.10 Infectious diseases: Parasitic |
hsa05142 |
Chagas disease (American trypanosomiasis) |
| 6. Human Diseases |
6.10 Infectious diseases: Parasitic |
hsa05145 |
Toxoplasmosis |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05152 |
Tuberculosis |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05161 |
Hepatitis B |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05163 |
Human cytomegalovirus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05167 |
Kaposi sarcoma-associated herpesvirus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05169 |
Epstein-Barr virus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05170 |
Human immunodeficiency virus 1 infection |
| 6. Human Diseases |
6.1 Cancers: Overview |
hsa05205 |
Proteoglycans in cancer |
| 6. Human Diseases |
6.1 Cancers: Overview |
hsa05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
| 6. Human Diseases |
6.6 Cardiovascular diseases |
hsa05418 |
Fluid shear stress and atherosclerosis |